|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,154.40 INR | -1.20% |
|
-2.67% | +5.86% |
| 06-17 | Glenmark Pharmaceuticals Launches Methylene Blue Injection in US | MT |
| 06-11 | Glenmark Pharmaceuticals Unit Launches Acne Treatment Winlevi in European Markets | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.20% | -2.67% | -9.66% | -0.74% | +5.86% | +25.90% | +228.56% | +233.29% | +175.75% | 6.45B | |
| -0.62% | +1.33% | +1.00% | +3.86% | +8.32% | +10.38% | +85.95% | +177.10% | +140.75% | 47.38B | |
| +0.51% | +3.61% | -3.67% | -4.43% | +22.79% | +53.73% | +106.19% | +129.90% | +131.17% | 35.48B | |
| +0.15% | +6.53% | +1.54% | +15.92% | -4.71% | -4.15% | +42.69% | +50.46% | +194.47% | 12.33B | |
| +0.19% | +2.86% | +1.44% | +22.83% | +20.46% | +12.18% | +92.99% | +76.51% | +244.13% | 11.65B | |
| -0.57% | +0.38% | +2.94% | +14.63% | +29.31% | +36.72% | +124.36% | +152.40% | +354.15% | 8.88B | |
| +0.99% | +4.52% | -1.53% | +2.85% | +24.28% | +21.27% | +46.91% | +54.80% | +131.32% | 7.21B | |
| +1.58% | +5.71% | +0.44% | -6.73% | +9.44% | +53.88% | -9.81% | -5.34% | -43.86% | 6.91B | |
| -3.83% | -0.76% | -10.05% | -51.28% | -39.15% | -35.52% | -1.70% | -6.66% | +14.25% | 4.94B | |
| -2.31% | +3.76% | +5.28% | +13.27% | +14.86% | +26.17% | +111.86% | +144.11% | +222.57% | 4.21B | |
| +0.66% | +0.39% | +13.49% | +21.03% | +32.59% | +30.68% | -13.49% | -2.61% | -55.12% | 4.18B | |
| -0.16% | -2.28% | +10.97% | +65.21% | +35.89% | +19.81% | +745.61% | +247.45% | +118.76% | 3.39B | |
| -7.68% | -16.96% | -40.11% | -78.95% | -9.46% | +38.30% | +246.22% | +300.95% | +2,067.87% | 3.21B | |
| -0.64% | -3.24% | -9.47% | -23.20% | -22.56% | -15.73% | +24.76% | -26.78% | - | 3.04B | |
| -0.81% | -3.18% | +3.26% | +11.55% | +11.31% | -7.37% | +76.98% | - | - | 2.98B | |
| -0.08% | -1.85% | +0.30% | -13.01% | -6.56% | -15.13% | +52.01% | +157.09% | +727.50% | 2.82B | |
| -0.81% | -1.61% | -3.88% | -7.26% | +1.02% | +32.89% | +71.99% | +17.59% | +79.59% | 2.71B | |
| 0.00% | -0.76% | -7.91% | -21.48% | -25.44% | -39.85% | +33.77% | +12.18% | +14.91% | 2.5B | |
| -6.79% | -2.72% | -21.76% | +0.12% | -3.10% | -33.56% | +14.11% | +79.35% | - | 2.14B | |
| -6.24% | -9.27% | -30.76% | -33.33% | -10.03% | +98.16% | +31.84% | +381.37% | +205.58% | 2.06B | |
| Average | -1.38% | -0.43% | -4.91% | -3.46% | +4.76% | +15.44% | +105.59% | +114.38% | +277.87% | 8.72B | |
| Weighted average by Cap. | -0.50% | +1.85% | -1.79% | +1.32% | +10.75% | +21.60% | +96.56% | +125.33% | +192.65% |
- Stock Market
- Stocks
- GLENMARK Stock
- Sector Glenmark Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
